31.03.2021
Reading : 69
Share :

A drug called Evrysdi, developed by Roche, offering home use, was approved by the EMA (European Medicines Agency) for the use of SMA patients of all types who are 2 months and older.
https://www.roche.com/media/releases/med-cor-2021-03-30.htm

ANNOUNCEMENTS
Eskişehir Web Tasarım